Vanaclocha Sebastián, Francisco
Body mass index in patients with moderate-to-severe psoriasis in Spain and its impact as an independent risk factor for therapy withdrawal: results of the Biobadaderm Registry. [artículo] - Journal of the European Academy of Dermatology and Venereology : JEADV, 2014 - 28(7):907-14.
Formato Vancouver:
Carrascosa JM, Vilavella M, García-Doval I, Carretero G, Vanaclocha F, Daudén E et al; BIOBADADERM Study Group. Body mass index in patients with moderate-to-severe psoriasis in Spain and its impact as an independent risk factor for therapy withdrawal: results of the Biobadaderm Registry. J Eur Acad Dermatol Venereol. 2014 Jul;28(7):907-14.
PMID: 23848131
Contiene 24 referencias
There are few data on the prevalence of obesity in the general psoriasis population and on the real impact of obesity on the management of psoriasis patients in the clinical setting.
Body mass index in patients with moderate-to-severe psoriasis in Spain and its impact as an independent risk factor for therapy withdrawal: results of the Biobadaderm Registry. [artículo] - Journal of the European Academy of Dermatology and Venereology : JEADV, 2014 - 28(7):907-14.
Formato Vancouver:
Carrascosa JM, Vilavella M, García-Doval I, Carretero G, Vanaclocha F, Daudén E et al; BIOBADADERM Study Group. Body mass index in patients with moderate-to-severe psoriasis in Spain and its impact as an independent risk factor for therapy withdrawal: results of the Biobadaderm Registry. J Eur Acad Dermatol Venereol. 2014 Jul;28(7):907-14.
PMID: 23848131
Contiene 24 referencias
There are few data on the prevalence of obesity in the general psoriasis population and on the real impact of obesity on the management of psoriasis patients in the clinical setting.
